Literature DB >> 16207755

Genetic and biochemical analysis of the role of Egfr in the morphogenetic furrow of the developing Drosophila eye.

Aloma B Rodrigues1, Erica Werner, Kevin Moses.   

Abstract

A key event in patterning the developing Drosophila compound eye is the progressive restriction of the transcription factor Atonal in the morphogenetic furrow. The Atonal pattern evolves from expression in all cells to an over-dispersed pattern of single founder cells (the future R8 photoreceptors). This restriction involves Notch-mediated lateral inhibition. However, there have been inconsistent data on a similar proposed role for the Egf receptor (Egfr). Experiments using a conditional Egfr mutation (Egfr(tsla)) suggested that Egfr does not regulate Atonal restriction, whereas experiments using Egfr-null mosaic Minute+ clones suggested that it does. Here, we have re-examined both approaches. We report that the lesion in Egfr(tsla) is a serine to phenylalanine change in a conserved extracellular ligand-binding domain. We show by biochemical and genetic approaches that the Egfr(tsla) protein is rapidly and completely inactivated upon shift to the non-permissive temperature. We also find that on temperature shift the protein moves from the cell surface into the cell. Finally, we report a flaw in the Egfr-null mosaic Minute+ clone approach. Thus, we demonstrate that Egfr does not play a role in the initial specification or spacing of ommatidial founder cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207755     DOI: 10.1242/dev.02058

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  15 in total

1.  Non-cell-autonomous control of denticle diversity in the Drosophila embryo.

Authors:  Stacie A Dilks; Stephen DiNardo
Journal:  Development       Date:  2010-04       Impact factor: 6.868

Review 2.  Regulatory mechanisms of EGFR signalling during Drosophila eye development.

Authors:  Marianne Malartre
Journal:  Cell Mol Life Sci       Date:  2016-03-02       Impact factor: 9.261

3.  The Drosophila Epidermal Growth Factor Receptor does not act in the nucleus.

Authors:  Maximilien Courgeon; Dan Qing He; Hui Hua Liu; Kevin Legent; Jessica E Treisman
Journal:  J Cell Sci       Date:  2018-09-20       Impact factor: 5.285

4.  Trafficking of the EGFR ligand Spitz regulates its signaling activity in polarized tissues.

Authors:  Josefa Steinhauer; Hui Hua Liu; Eli Miller; Jessica E Treisman
Journal:  J Cell Sci       Date:  2013-07-31       Impact factor: 5.285

5.  Drosophila Vps4 promotes Epidermal growth factor receptor signaling independently of its role in receptor degradation.

Authors:  Kevin Legent; Hui Hua Liu; Jessica E Treisman
Journal:  Development       Date:  2015-03-19       Impact factor: 6.868

6.  A screen for X-linked mutations affecting Drosophila photoreceptor differentiation identifies Casein kinase 1α as an essential negative regulator of wingless signaling.

Authors:  Kevin Legent; Josefa Steinhauer; Magali Richard; Jessica E Treisman
Journal:  Genetics       Date:  2011-11-17       Impact factor: 4.562

7.  smoothened and thickveins regulate Moleskin/Importin 7-mediated MAP kinase signaling in the developing Drosophila eye.

Authors:  Alysia D Vrailas; Daniel R Marenda; Summer E Cook; Maureen A Powers; James A Lorenzen; Lizabeth A Perkins; Kevin Moses
Journal:  Development       Date:  2006-03-15       Impact factor: 6.868

8.  Myopic acts in the endocytic pathway to enhance signaling by the Drosophila EGF receptor.

Authors:  Grant I Miura; Jean-Yves Roignant; Michel Wassef; Jessica E Treisman
Journal:  Development       Date:  2008-04-23       Impact factor: 6.868

9.  Delta and Egfr expression are regulated by Importin-7/Moleskin in Drosophila wing development.

Authors:  Alysia D Vrailas-Mortimer; Neena Majumdar; Ginnene Middleton; Evan M Cooke; Daniel R Marenda
Journal:  Dev Biol       Date:  2007-06-21       Impact factor: 3.582

Review 10.  Pattern formation in the Drosophila eye disc.

Authors:  Jean-Yves Roignant; Jessica E Treisman
Journal:  Int J Dev Biol       Date:  2009       Impact factor: 2.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.